Immediate implantation of ultrafine fiber slow-release system based on cell electrospinning to induce osteogenesis of mesenchymal stem cells
Regenerative Biomaterials · 02.01.2024 · 11
DOI: 10.1093/rb/rbad113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 25.12.2023. Verfasst von Tao Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Department of Science and Technology of Guizhou Province, Doctor start-up Fund of Affiliated Hospital of Guizhou Medical University.
Abstract (Originalsprache)
This study presents the development and evaluation of a poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (P34HB) ultrafine fiber slow-release system for in vivo osteogenic induction of human umbilical cord mesenchymal stem cells (HUCMSCs). Utilizing dual-nozzle and cell electrospinning techniques, the system encapsulates L-ascorbic acid-2-phosphate magnesium (ASP), β-glycerophosphate sodium and dexamethasone (DEX) within the fibers, ensuring sustained osteogenic differentiation. The scaffold’s morphology, characterization, hydrophilicity, mechanical properties and cellular behavior were examined. Immediate subcutaneous implantation in rabbits was conducted to observe its ectopic osteogenic induction effect. Successfully fabricated P34HB ultrafine fiber slow-release system. Characterization confirmed the uniform distribution of HUCMSCs and inducing components within the scaffold, with no chemical reactions affecting the active components. In vitro tests showcased a prolonged release of DEX and ASP, while biocompatibility assays highlighted the scaffold’s suitability for cellular growth. Alizarin Red, type I collagen, and osteopontin (OPN) staining verified the scaffold’s potent osteogenic induction effect on HUCMSCs. Notably, immediate implantation into New Zealand White rabbits led to significant new bone formation within 8 weeks. These findings underscore the system’s potential for immediate in vivo implantation without prior in vitro induction, marking a promising advancement in bone tissue engineering.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
- Department of Orthopaedics, The First People's Hospital of Guiyang, Guiyang 550004, China.
- Center for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Guiyang 550004, China.
- Department of Otolaryngology Head and Neck Surgery, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China.
- Department of Dental implant, Stomatological Hospital of Guiyang, Guiyang 550000, China.
ORCID-Profile: Chuan Ye
Förderung
- National Natural Science Foundation of China
- Department of Science and Technology of Guizhou Province
- Doctor start-up Fund of Affiliated Hospital of Guizhou Medical University
- Affiliated Hospital of Guizhou Medical University
Zitieren
APA
Lu, T., Yang, L., Li, Z., Liu, Y., Xu, S., & Ye, C. (2024). Immediate implantation of ultrafine fiber slow-release system based on cell electrospinning to induce osteogenesis of mesenchymal stem cells. Regenerative Biomaterials, 11. https://doi.org/10.1093/rb/rbad113
Vancouver
Lu T, Yang L, Li Z, Liu Y, Xu S, Ye C. Immediate implantation of ultrafine fiber slow-release system based on cell electrospinning to induce osteogenesis of mesenchymal stem cells. Regenerative Biomaterials. 2024;11. doi:10.1093/rb/rbad113
BibTeX
@article{Lu2024,
author = {Lu, Tao and Yang, Long and Li, Zhuoyang and Liu, Yin and Xu, Shun'en and Ye, Chuan},
title = {Immediate implantation of ultrafine fiber slow-release system based on cell electrospinning to induce osteogenesis of mesenchymal stem cells},
journal = {Regenerative Biomaterials},
year = {2024},
volume = {11},
doi = {10.1093/rb/rbad113}
}
EUVIMED